Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 20 November 2025

 
 
 
   

Can the Critical Medicines Act deliver for Europe?

 
By Nathalie Moll, Director General, EFPIA

If appropriately designed, the CMA offers an opportunity to improve medicines availability and strengthen Europe’s competitiveness.

As trilogue discussions on the Critical Medicines Act (CMA) approach, its potential effects on medicine supply, patient access and Europe’s competitiveness are increasingly in focus.

From an industry standpoint, several considerations are central to understanding how this act can best achieve its objectives and support a robust pharmaceutical ecosystem in Europe. 

Read more


 
 
 
   

Blogs

 
Thumbnail

The Unseen Arsenal: Why health is the new economic battleground (Guest blog)
18 November 2025

As geopolitical tensions intensify, a nation’s true strength may lie in its ability to invest in human capital and ensure... Read more

 
 
 
   

AMR Awareness Week

As we mark AMR Awareness Week, EFPIA was honoured to participate in the Danish EU Presidency High-Level Conference on AMR to discuss how to accelerate the development of new, effective antibiotics.

Antimicrobial resistance is a growing global health threat. Despite strong prevention and stewardship efforts, resistance remains inevitable. Without effective antimicrobials, routine medical treatments and procedures become dangerous again. Yet, today’s pipeline remains alarmingly thin because the market model is broken. These medicines must be used rarely, yet always be available.

How can Europe tackle AMR? Find out more here.

 
 
 
 
   

Europe has a choice to make

New treatments for Hep C now cure over 98% of patients, replacing a lifetime of costly care.
In Belgium, that saves €11,000 per patient.

Will Europe invest in innovative treatments like this or pay the cost of care?

Learn more here

 
 
 
 
   

Events

 

“Europe’s Beating Cancer Plan in Action: National Implementation for the Future” report launch...
01 December 2025 (Online)

The EFPIA Oncology Platform and Cancer Patients Europe are delighted to invite you to the launch webinar of their new... Read more

World AIDS Day 2025: Redefining the Journey
01 December 2025 (Online)

The event will feature the latest data on HIV/AIDS from ECDC and the WHO Regional Office for Europe. Read more

EMA Information Day on submission predictability of initial marketing authorisation
03 December 2025 (Online)

The focus of this interactive Information Day will be to enhance a common understanding, raise awareness of the challenges... Read more

Future-proofing Alzheimer’s care: scaling innovation for a healthier Europe
04 December 2025 (Online)

Explore how new therapies and scalable solutions can transform care pathways and strengthen health systems. Read more

 
 
 
   

What we are reading

 
The status quo of the development of decentralized clinical trials
On 19 November 2025 (Frontiers)

Decentralized clinical trials (DCTs) have emerged as a transformative model in new drug development, offering alternatives... Read more

The 25 most powerful ideas of the 21st century (so far), picked by the world’s top thinkers...
On 15 November 2025 (Science Focus)

We asked the world's foremost minds to highlight some of the game-changing scientific breakthroughs shaping our world... Read more

How to cure type 1 diabetes: transforming research into policy change
On 14 November 2025 (IHI)

The EDENT1FI and INNODIA projects have contributed to a set of recommendations for policymakers published by the... Read more

Animal testing phaseout needs partnership delivery model
On 13 November 2025 (Euractiv)

Europe’s shift beyond animal testing depends on partnership, the EPAA’s collaborative model is emerging as the engine... Read more